Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by M. D. Sadler
Editorial: Genotype 3 HCV-who Still Needs Ribavirin in a Pan-Genotypic Era?
Alimentary Pharmacology and Therapeutics
Hepatology
Pharmacology
Gastroenterology
Related publications
Editorial: Genotype 3 HCV-who Still Needs Ribavirin in a Pan-Genotypic Era? Authors’ Reply
Alimentary Pharmacology and Therapeutics
Hepatology
Pharmacology
Gastroenterology
Sofosbuvir and Velpatasvir: A Complete Pan-Genotypic Treatment for HCV Patients
Turkish Journal of Gastroenterology
Gastroenterology
In Vitro Susceptibility of HCV Genotype 1 Through 6 Clinical Isolates to the Pan-Genotypic NS3/4A Inhibitor Voxilaprevir
Journal of Clinical Microbiology
Microbiology
Ribavirin Dosage in Patients With HCV Genotypes 2 and 3 Who Completed Short Therapy With Peg-Interferon Α-2b and Ribavirin
Alimentary Pharmacology and Therapeutics
Hepatology
Pharmacology
Gastroenterology
Editorial: Should We Abandon HCV Genotype Testing? Maybe
Alimentary Pharmacology and Therapeutics
Hepatology
Pharmacology
Gastroenterology
Letter: Chronic Hepatitis C Genotype 3 Infection - Still a Hurdle Toward a Direct-Acting Anti-Viral-Induced HCV Cure?
Alimentary Pharmacology and Therapeutics
Hepatology
Pharmacology
Gastroenterology
Characterization of Nonrapid Virologic Response Patients Infected With HCV Genotype 1 Who May Relapse After Standard Therapy With Peginterferon Plus Ribavirin
Journal of Viral Hepatitis
Virology
Hepatology
Infectious Diseases
In Vitro Antiviral Profile of Ruzasvir: A Potent and Pan-Genotype Inhibitor of HCV NS5A
Antimicrobial Agents and Chemotherapy
Infectious Diseases
Pharmacology
Editorial: A Psychology of Aging: Who Needs It?
Canadian Journal on Aging
Gerontology
Geriatrics
Health
Home Care
Community
